The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_005249.5(FOXG1):c.430G>A (p.Glu144Lys)

CA206112

211032 (ClinVar)

Gene: FOXG1 (HGNC:2290)
Condition: FOXG1 disorder (MONDO:0100040)
Inheritance Mode: Autosomal dominant inheritance
UUID: 927bf4da-dc44-4398-9fdb-e3384aff5a5a
Approved on: 2025-08-27
Published on: 2025-10-01

HGVS expressions

NM_005249.5:c.430G>A
NM_005249.5(FOXG1):c.430G>A (p.Glu144Lys)
NC_000014.9:g.28767709G>A
CM000676.2:g.28767709G>A
NC_000014.8:g.29236915G>A
CM000676.1:g.29236915G>A
NC_000014.7:g.28306666G>A
NG_009367.1:g.5629G>A
ENST00000706482.1:c.430G>A
ENST00000313071.7:c.430G>A
ENST00000313071.6:c.430G>A
NM_005249.4:c.430G>A
More

Uncertain Significance

Met criteria codes 3
BP4 PS4_Supporting PM2_Supporting
Not Met criteria codes 4
PS1 PM5 PM1 PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for FOXG1 Version 5.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Glu144Lys variant in FOXG1 is absent from gnomAD v4.1 (PM2_Supporting). The p.Glu144Lys variant has been observed in at least 2 individuals with neurodevelopmental phenotypes (internal databases - GeneDx and University of Chicago) (PS4_Supporting). The computational predictor REVEL gives a score of 0.112, which is below the threshold of 0.290, evidence that does not predict a damaging effect on FOXG1 function (BP4). In summary, the p.Glu144Lys variant in FOXG1 is classified as uncertain significance based on the ACMG/AMP criteria (PM2_Supporting, PS4_Supporting, BP4). (FOXG1 Specifications v.5.0.0; curation approved on 8/27/2025)
Met criteria codes
BP4
The computational predictor REVEL gives a score of 0.112, which is below the threshold of 0.290, evidence that does not predict a damaging effect on FOXG1 function (BP4).
PS4_Supporting
The p.Glu144Lys variant has been observed in at least 2 individuals with neurodevelopmental phenotypes (internal database - GeneDx and University of Chicago).
PM2_Supporting
The p.Glu144Lys variant in FOXG1 is absent from gnomAD v4.1 (PM2_Supporting).
Not Met criteria codes
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PVS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.